| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2009.03.061 |
| P698 | PubMed publication ID | 19446184 |
| P50 | author | Chul-Joong Kim | Q73844358 |
| Haryoung Poo | Q92867308 | ||
| P2093 | author name string | Yeup Yoon | |
| Jun Han Lee | |||
| Min-Suk Song | |||
| Moon-Hee Sung | |||
| Philippe Noriel Q Pascua | |||
| Young Ki Choi | |||
| Yun Hee Baek | |||
| Ho-Jin Moon | |||
| Kyu-Jin Woo | |||
| Taek-Kyu Oh | |||
| P2860 | cites work | Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. | Q30357294 |
| Emergence and predominance of an H5N1 influenza variant in China. | Q30357743 | ||
| Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. | Q30363500 | ||
| H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. | Q30371435 | ||
| Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model. | Q30372159 | ||
| Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus | Q33238916 | ||
| Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. | Q33782142 | ||
| Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines | Q33944041 | ||
| Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals | Q33987458 | ||
| Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China | Q34326581 | ||
| Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea | Q36944707 | ||
| Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus | Q40623724 | ||
| Eight-plasmid system for rapid generation of influenza virus vaccines | Q40712787 | ||
| Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia | Q43175466 | ||
| Field and laboratory findings of the first incursion of the Asian H5N1 highly pathogenic avian influenza virus in Africa | Q43176307 | ||
| Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission | Q43177564 | ||
| Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus | Q43209132 | ||
| Poultry and the influenza H5N1 outbreak in Hong Kong, 1997: abridged chronology and virus isolation | Q43209295 | ||
| International disease monitoring, October to December 2005. | Q44927507 | ||
| Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets | Q45411939 | ||
| Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. | Q45729695 | ||
| Ferrets and the challenges of H5N1 vaccine formulation | Q79738854 | ||
| H5N1 viruses and vaccines | Q21131612 | ||
| Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets | Q21563426 | ||
| Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. | Q24521607 | ||
| Genome analysis linking recent European and African influenza (H5N1) viruses | Q24652627 | ||
| Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors | Q30230269 | ||
| Molecular evolution of H6 influenza viruses from poultry in Southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry | Q30233566 | ||
| A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans | Q30233717 | ||
| Plasmid-only rescue of influenza A virus vaccine candidates. | Q30329368 | ||
| Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. | Q30351073 | ||
| The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. | Q30352362 | ||
| Development of effective vaccines against pandemic influenza. | Q30352566 | ||
| Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. | Q30354976 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | avian influenza | Q43987 |
| P304 | page(s) | 3145-3152 | |
| P577 | publication date | 2009-04-09 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets | |
| P478 | volume | 27 |
| Q30385847 | Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. |
| Q52657340 | Comparison of the pathogenic potential of highly pathogenic avian influenza (HPAI) H5N6, and H5N8 viruses isolated in South Korea during the 2016-2017 winter season. |
| Q40569036 | Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus |
| Q28749544 | Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection |
| Q30418752 | Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models |
| Q30405129 | Genetic characterization and pathogenicity assessment of highly pathogenic H5N1 avian influenza viruses isolated from migratory wild birds in 2011, South Korea |
| Q30380556 | Growth and Pathogenic Potential of Naturally Selected Reassortants after Coinfection with Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Viruses. |
| Q30427806 | H5N1 pathogenesis studies in mammalian models |
| Q30372360 | Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice. |
| Q40526558 | Injectable and Pathogen-Mimicking Hydrogels for Enhanced Protective Immunity against Emerging and Highly Pathogenic Influenza Virus |
| Q38461049 | Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. |
| Q35666065 | Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection |
| Q82738285 | Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations |
| Q30367861 | Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors. |
| Q24607378 | Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination |
| Q30427778 | Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus. |
| Q30379209 | Understanding influenza transmission, immunity and pandemic threats |
Search more.